Immune Biomarker Study for Head and Neck Cancer
Immune Biomarker Study for Head and Neck Cancer
Recruiting · NCT05375266 · Registry updated 2023-05-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immune Biomarker Study for Head and Neck Cancer | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, head and neck cancer, hypopharynx cancer, laryngeal disorder, laryngeal neoplasm, larynx cancer, mouth disorder, neoplasm, oral cavity cancer, otorhinolaryngologic disease, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2023-05-17 | NCT05375266 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital Augsburg | 25 |
| University Hospital Erlangen | 16 |
| University Hospital Regensburg | 17 |
| University of Erlangen-Nürnberg Medical School | 47 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ENT - Head and Neck Surgery Department | Erlangen | Germany | 1 |
| Maxillo-Facial-Surgery Department | Erlangen | Germany | 1 |
| Radiation Oncology Department | Erlangen | Germany | 1 |